Back to today’s briefing

Story perspectives

Breakthrough Therapy Halts Adult-Onset Leukoencephalopathy Progression

7/12/2025

50 9

Summary

Story summary

Researchers at Fudan University have made a groundbreaking advancement with their microglia replacement therapy, successfully halting the progression of adult-onset leukoencephalopathy in eight patients over two years. This innovative treatment not only offers hope for ALSP but also opens doors for tackling other neurological disorders, including Alzheimer’s, by replacing damaged cells with healthy ones.

1 of 1

Story summary

Researchers at Fudan University have made a groundbreaking advancement with their microglia replacement therapy, successfully halting the progression of adult-onset leukoencephalopathy in eight patients over two years. This innovative treatment not only offers hope for ALSP but also opens doors for tackling other neurological disorders, including Alzheimer’s, by replacing damaged cells with healthy ones.